Xenetic stockholders approve increase in authorized common stock from 50M to 100M shares

Xenetic Biosciences, Inc.

Proposal Four passed: 7,204,486 For, 1,131,034 Against, 110,245 Abstained, no broker non-votes.
Amendment to Articles of Incorporation increases authorized common stock from 50M to 100M shares.
Annual meeting reconvened on Dec. 21, 2022 solely for this proposal after initial adjournment on Dec. 7, 2022.
No other matters were considered or voted upon at the meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Xenetic Biosciences, Inc. shareholders approved Amendment to increase authorized common stock from 50,000,000 to 100,000,000 shares at the 2022-12-21 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2022-12-21

Exact text from the filing

Proposal Four : The Company’s stockholders voted upon and approved and adopted an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of the Company’s common stock from 50,000,000 shares to 100,000,000 shares. The votes on this proposal were as follows: For Against Abstained Broker Non-Votes 7,204,486 1,131,034 110,245 –

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Xenetic Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-008623

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.